Skip to main content
Daily Report

Daily Sepsis Research Analysis

04/30/2025
3 papers selected
3 analyzed

Three impactful studies advance sepsis science across mechanisms and bedside decision support. A mechanistic paper links lactate-driven HMGB1 lactylation in macrophages to NET formation via cGAS/STING, illuminating a therapeutic axis in sepsis-associated acute kidney injury. Two translational/clinical studies show promise for precision diagnosis in preterm neonates via metabolomics and for ED airway decision support in septic shock using explainable machine learning.

Summary

Three impactful studies advance sepsis science across mechanisms and bedside decision support. A mechanistic paper links lactate-driven HMGB1 lactylation in macrophages to NET formation via cGAS/STING, illuminating a therapeutic axis in sepsis-associated acute kidney injury. Two translational/clinical studies show promise for precision diagnosis in preterm neonates via metabolomics and for ED airway decision support in septic shock using explainable machine learning.

Research Themes

  • Immunometabolism and DAMP signaling (lactate-HMGB1-cGAS/STING) in sepsis
  • Precision diagnostics for neonatal sepsis using metabolomics
  • Machine learning decision support for airway management in septic shock

Selected Articles

1. Lactate-induced macrophage HMGB1 lactylation promotes neutrophil extracellular trap formation in sepsis-associated acute kidney injury.

74.5Level IIICase-control
Cell biology and toxicology · 2025PMID: 40304798

In human SAKI and murine CLP models, elevated lactate drove HMGB1 accumulation and lactylation in macrophages, enhancing NET formation and worsening kidney injury via cGAS/STING activation. Exosome-mediated HMGB1 transfer from macrophages to neutrophils linked immunometabolism to innate effector activation, nominating HMGB1 lactylation as a therapeutic target.

Impact: Identifies a lactate–HMGB1–cGAS/STING axis that mechanistically links sepsis immunometabolism to NET-driven organ injury and offers a druggable node. The integration of human samples, mouse models, and mechanistic assays strengthens translational relevance.

Clinical Implications: Therapeutic strategies that reduce HMGB1 lactylation, block HMGB1 signaling, modulate lactate handling, or inhibit cGAS/STING may mitigate SAKI. Lactate levels could serve as a biomarker to stratify risk and guide such interventions.

Key Findings

  • Elevated blood lactate correlated with increased HMGB1 in SAKI patients.
  • Lactate increased HMGB1 expression, promoted NET formation, and worsened kidney injury in CLP mice.
  • Lactate induced HMGB1 lactylation in macrophages and exosomal HMGB1 transfer, triggering neutrophil mtDNA release and cGAS/STING activation.

Methodological Strengths

  • Translational design spanning human samples, in vivo CLP model, and in vitro co-culture.
  • Mechanistic dissection with exosome isolation, co-immunoprecipitation, immunofluorescence, ELISA, and Western blotting.

Limitations

  • Human component appears observational with limited sample characterization.
  • No interventional blockade of HMGB1/lactylation or cGAS/STING in patients; clinical efficacy remains untested.

Future Directions: Evaluate pharmacologic inhibitors of HMGB1 lactylation or cGAS/STING in preclinical SAKI models; prospectively validate lactate/HMGB1 as biomarkers and test targeted therapies in early-phase clinical trials.

BACKGROUND: Neutrophils play a key role in sepsis-associated acute kidney injury (SAKI), a common and life-threatening complication of organ failure. High mobility group box 1 (HMGB1) modulates inflammatory responses and the formation of neutrophil extracellular traps (NETs). The present work aimed to explore whether HMGB1 lactylation promotes NET formation and exacerbates SAKI. METHODS: Venous blood samples were collected from healthy volunteers and SAKI patients. A SAKI mouse model was established using the cecal ligation and puncture method. A coculture system of macrophage-derived exosomes and neutrophils was established. Macrophage-derived exosomes were isolated and identified. ELISAs, immunofluorescence staining, coimmunoprecipitation, and Western blotting were utilized to determine protein levels. RESULTS: Elevated blood lactate levels were associated with increased HMGB1 levels in patients with SAKI. In mouse models, lactate increased HMGB1 expression, promoted NET formation, and exacerbated SAKI. Lactate stimulated M1 macrophages to secrete exosomes, leading to the accumulation and release of HMGB1 in the cytoplasm. Additionally, lactate promoted HMGB1 lactylation in macrophages, triggering the release of mitochondrial DNA from neutrophils and activating the cyclic GMP‒AMP synthase/stimulator of interferon genes pathway. CONCLUSION: This study revealed that lactate-induced HMGB1 lactylation in macrophages plays a role in promoting NET formation in SAKI through the cGAS/STING pathway. These findings suggest that HMGB1 could be a potential target for therapeutic intervention in SAKI.

2. Survival of the Littlest: Navigating Sepsis Diagnosis beyond Inflammation in Preterm Neonates.

69Level IIICase-control
Journal of proteome research · 2025PMID: 40305123

Targeted metabolomics of 227 samples from 94 preterm neonates revealed shared and progressive metabolic shifts from control to SINS to sepsis, with sex- and pathogen-specific signatures. A 5-metabolite plus IL-6 model distinguished SINS from sepsis at clinical suspicion (AUC 0.79; sensitivity 0.85; specificity 0.82), supporting precision diagnostics to guide antibiotics.

Impact: Provides an explainable, biologically anchored metabolomic panel for early neonatal sepsis discrimination, addressing overuse of antibiotics and diagnostic delays in a vulnerable population.

Clinical Implications: If validated externally, the metabolite+IL-6 panel could triage preterm neonates at suspicion, reducing unnecessary antibiotics while expediting treatment for true sepsis. Sex- and pathogen-specific signatures support personalized care.

Key Findings

  • Metabolic changes were shared between SINS and sepsis and progressed from control to SINS to sepsis.
  • Distinct sex-specific (male pro-inflammatory, female anti-inflammatory) and pathogen-specific metabolic profiles were observed.
  • A panel of 5 metabolic features plus IL-6 discriminated SINS from sepsis at clinical suspicion (AUC 0.79; sensitivity 0.85; specificity 0.82).

Methodological Strengths

  • Comprehensive LC–MS profiling with linear mixed-effects modeling, LASSO, and logistic regression.
  • Biologically plausible stratification by sex and pathogen, and analysis across multiple clinical states (control, SINS, sepsis).

Limitations

  • Observational case-control design with moderate sample size and no external validation; potential overfitting risk.
  • Single healthcare setting limits generalizability; timing of sampling relative to clinical events may vary.

Future Directions: Multicenter external validation and prospective impact studies integrating the panel into neonatal sepsis pathways; exploration of pathogen- and sex-tailored thresholds and therapeutic modulation of implicated metabolic pathways.

Sepsis diagnosis in preterm neonates is challenging due to symptom overlap with non-infectious inflammatory conditions, and slow, unreliable diagnostic practices. This case-control study aims to elucidate sepsis pathophysiology, and identify metabolic biomarkers for timely, accurate diagnosis, to prevent rapid health deterioration and unnecessary antibiotic use. Liquid chromatography-mass spectrometry was performed on 227 plasma samples, obtained from 94 preterm neonates, to measure 317 metabolites encompassing amines and signaling lipids. Linear mixed-effect modeling, LASSO and logistic regression models were calculated to assess metabolic alterations across control, systemic inflammation-no sepsis (SINS), and sepsis groups. Stratification by sex and pathogen type allowed identification of sex-specific responses and pathogen-driven variations in sepsis. Key findings include (i) shared metabolic changes in SINS and sepsis, (ii) progressive alterations from control to SINS to sepsis, and (iii) sepsis-specific markers. Males exhibited a pro-inflammatory phenotype while females showed an anti-inflammatory phenotype in response to sepsis. Gram-positive and gram-negative bacterial sepsis revealed distinct metabolic profiles. A diagnostic model comprising 5 metabolic features and IL-6 distinguished SINS from sepsis at clinical suspicion (AUC 0.79, sensitivity 0.85, specificity 0.82). These insights highlight the potential of metabolomics to revolutionize neonatal sepsis management with precision diagnostics and personalized treatment strategies.

3. Using machine learning techniques for early prediction of tracheal intubation in patients with septic shock: a multi-center study in South Korea.

64.5Level IIICohort
Acute and critical care · 2025PMID: 40302563

Across 21 EDs (n=4,762), an XGBoost model predicted 24-hour intubation in septic shock with AUROC 0.829 and F1 0.654. SHAP analysis highlighted post-fluid lactate, suspected lung infection, initial pH, SOFA, and respiratory rate as key drivers, enabling explainable risk stratification at triage.

Impact: Delivers a scalable, explainable ML tool for early airway decision support in septic shock, using routinely available variables and multicenter data.

Clinical Implications: Could be integrated into ED workflows to flag high-risk patients for early airway planning, resource allocation, and closer monitoring while maintaining transparency via SHAP explanations.

Key Findings

  • In 4,762 septic shock patients, 31% required intubation within 24 hours; XGBoost achieved AUROC 0.829 and F1 0.654.
  • Top predictive features included lactate after initial fluids, suspected lung infection, initial pH, SOFA score, and respiratory rate.
  • Model development used stratified five-fold cross-validation and grid search, with SHAP values for interpretability.

Methodological Strengths

  • Large, multicenter dataset with stratified cross-validation and explainability via SHAP.
  • Use of routinely available ED features supports real-world deployment.

Limitations

  • Retrospective design and lack of prospective external validation; clinical thresholds and workflow integration remain untested.
  • Intubation decisions are clinician-dependent, introducing indication bias.

Future Directions: Prospective, external validation and randomized or stepped-wedge implementation studies to test clinical impact; calibration for different health systems and integration into ED EHRs.

BACKGROUND: Patients with septic shock frequently require tracheal intubation in the emergency department (ED). However, the criteria for tracheal intubation are subjective, based on physician experience, or require serial evaluations over relatively long intervals to make accurate predictions, which might not be feasible in the ED. We used supervised learning approaches and features routinely available during the initial stages of evaluation and resuscitation to stratify the risks of tracheal intubation within a 24-hour time window. METHODS: We retrospectively analyzed the data of patients diagnosed with septic shock based on the SEPSIS-3 criteria across 21 university hospital EDs in the Republic of Korea. A principal component analysis revealed a complex, non-linear decision boundary with respect to the application of tracheal intubation within a 24-hour time window. Stratified five-fold cross validation and a grid search were used with extreme gradient boost. Shapley values were calculated to explain feature importance and preferences. RESULTS: In total, data for 4,762 patients were analyzed; within that population, 1,486 (31%) were intubated within a 24-hour window, and 3,276 (69%) were not. The area under the receiver operating characteristic curve and F1 scores for intubation within a 24-hour window were 0.829 (95% CI, 0.801-0.878) and 0.654 (95% CI, 0.627-0.681), respectively. The Shapley values identified lactate level after initial fluids, suspected lung infection, initial pH, Sequential Organ Failure Assessment score at enrollment, and respiratory rate at enrollment as important features for prediction. CONCLUSIONS: An extreme gradient boosting machine can moderately discriminate whether intubation is warranted within 24 hours of the recognition of septic shock in the ED.